Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
This study has been completed.
Study NCT01285323   Information provided by Teva Pharmaceutical Industries

First Received on January 25, 2011.   Last Updated on August 20, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial